Time trends in herpesvirus seroepidemiology among Swedish adults
© 2024. The Author(s)..
BACKGROUND: Human herpesviruses are widespread among the human population. The infections often occur unnoticed, but severe disease as well as long-term sequelae are part of the symptom spectrum. The prevalence varies among subpopulations and with time. The aim of this study was to describe the seroprevalence of Immunoglobulin G against Herpes simplex 1, Herpes simplex 2, Epstein-Barr virus and Cytomegalovirus in the adult Swedish population over a time period of several decades.
METHODS: Serum samples (n = 892) from biobanks, originating from 30-year-old women, 50-year-old men and 50-year-old women sampled between 1975 and 2018, were analyzed for presence of anti-herpesvirus antibodies. Linear regression analysis was used to test for a correlation between birth year and seroprevalence. Multiple linear regression analysis was used to differentiate between other factors such as age and gender.
RESULTS: Birth year correlated negatively with the prevalence of immunoglobulin G against Herpes simplex 1 and Epstein-Barr virus (p = 0.004 and 0.033), and positively with Immunoglobulin G against Cytomegalovirus (p = 0.039). When participant categories were analyzed separately, birth year correlated negatively with the prevalence of Immunoglobulin G against Herpes simplex 1 and Herpes simplex 2 (p = 0.032 and 0.028) in 30-year-old women, and with the prevalence of Immunoglobulin G against Cytomegalovirus in 50-year-old men (p = 0.011).
CONCLUSIONS: The prevalence of Immunoglobulin G against Herpes simplex 1, Herpes simplex 2 and Epstein-Barr virus decreases in later birth cohorts. This indicates a trend of declining risk of getting infected with these viruses as a child and adolescent.
Medienart: |
E-Artikel |
---|
Erscheinungsjahr: |
2024 |
---|---|
Erschienen: |
2024 |
Enthalten in: |
Zur Gesamtaufnahme - volume:24 |
---|---|
Enthalten in: |
BMC infectious diseases - 24(2024), 1 vom: 02. März, Seite 273 |
Sprache: |
Englisch |
---|
Beteiligte Personen: |
Olsson, Jan [VerfasserIn] |
---|
Links: |
---|
Themen: |
Antibodies, Viral |
---|
Anmerkungen: |
Date Completed 05.03.2024 Date Revised 12.03.2024 published: Electronic Citation Status MEDLINE |
---|
doi: |
10.1186/s12879-024-09155-w |
---|
funding: |
|
---|---|
Förderinstitution / Projekttitel: |
|
PPN (Katalog-ID): |
NLM369214412 |
---|
LEADER | 01000caa a22002652 4500 | ||
---|---|---|---|
001 | NLM369214412 | ||
003 | DE-627 | ||
005 | 20240313234606.0 | ||
007 | cr uuu---uuuuu | ||
008 | 240304s2024 xx |||||o 00| ||eng c | ||
024 | 7 | |a 10.1186/s12879-024-09155-w |2 doi | |
028 | 5 | 2 | |a pubmed24n1326.xml |
035 | |a (DE-627)NLM369214412 | ||
035 | |a (NLM)38431567 | ||
040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
041 | |a eng | ||
100 | 1 | |a Olsson, Jan |e verfasserin |4 aut | |
245 | 1 | 0 | |a Time trends in herpesvirus seroepidemiology among Swedish adults |
264 | 1 | |c 2024 | |
336 | |a Text |b txt |2 rdacontent | ||
337 | |a ƒaComputermedien |b c |2 rdamedia | ||
338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
500 | |a Date Completed 05.03.2024 | ||
500 | |a Date Revised 12.03.2024 | ||
500 | |a published: Electronic | ||
500 | |a Citation Status MEDLINE | ||
520 | |a © 2024. The Author(s). | ||
520 | |a BACKGROUND: Human herpesviruses are widespread among the human population. The infections often occur unnoticed, but severe disease as well as long-term sequelae are part of the symptom spectrum. The prevalence varies among subpopulations and with time. The aim of this study was to describe the seroprevalence of Immunoglobulin G against Herpes simplex 1, Herpes simplex 2, Epstein-Barr virus and Cytomegalovirus in the adult Swedish population over a time period of several decades | ||
520 | |a METHODS: Serum samples (n = 892) from biobanks, originating from 30-year-old women, 50-year-old men and 50-year-old women sampled between 1975 and 2018, were analyzed for presence of anti-herpesvirus antibodies. Linear regression analysis was used to test for a correlation between birth year and seroprevalence. Multiple linear regression analysis was used to differentiate between other factors such as age and gender | ||
520 | |a RESULTS: Birth year correlated negatively with the prevalence of immunoglobulin G against Herpes simplex 1 and Epstein-Barr virus (p = 0.004 and 0.033), and positively with Immunoglobulin G against Cytomegalovirus (p = 0.039). When participant categories were analyzed separately, birth year correlated negatively with the prevalence of Immunoglobulin G against Herpes simplex 1 and Herpes simplex 2 (p = 0.032 and 0.028) in 30-year-old women, and with the prevalence of Immunoglobulin G against Cytomegalovirus in 50-year-old men (p = 0.011) | ||
520 | |a CONCLUSIONS: The prevalence of Immunoglobulin G against Herpes simplex 1, Herpes simplex 2 and Epstein-Barr virus decreases in later birth cohorts. This indicates a trend of declining risk of getting infected with these viruses as a child and adolescent | ||
650 | 4 | |a Journal Article | |
650 | 4 | |a Cytomegalovirus | |
650 | 4 | |a Epidemiology | |
650 | 4 | |a Epstein-Barr virus | |
650 | 4 | |a Herpes | |
650 | 4 | |a Herpes simplex | |
650 | 4 | |a Immunoglobulin G | |
650 | 4 | |a Seroprevalence | |
650 | 4 | |a Time trends | |
650 | 7 | |a Antibodies, Viral |2 NLM | |
650 | 7 | |a Immunoglobulin G |2 NLM | |
700 | 1 | |a Nourmohammadi, Sema |e verfasserin |4 aut | |
700 | 1 | |a Honkala, Emma |e verfasserin |4 aut | |
700 | 1 | |a Johansson, Anders |e verfasserin |4 aut | |
700 | 1 | |a Hallmans, Göran |e verfasserin |4 aut | |
700 | 1 | |a Weidung, Bodil |e verfasserin |4 aut | |
700 | 1 | |a Lövheim, Hugo |e verfasserin |4 aut | |
700 | 1 | |a Elgh, Fredrik |e verfasserin |4 aut | |
773 | 0 | 8 | |i Enthalten in |t BMC infectious diseases |d 2001 |g 24(2024), 1 vom: 02. März, Seite 273 |w (DE-627)NLM11120089X |x 1471-2334 |7 nnns |
773 | 1 | 8 | |g volume:24 |g year:2024 |g number:1 |g day:02 |g month:03 |g pages:273 |
856 | 4 | 0 | |u http://dx.doi.org/10.1186/s12879-024-09155-w |3 Volltext |
912 | |a GBV_USEFLAG_A | ||
912 | |a GBV_NLM | ||
951 | |a AR | ||
952 | |d 24 |j 2024 |e 1 |b 02 |c 03 |h 273 |